Axitinib/nivolumab/pembrolizumab

Various toxicities: 2 case reports

    This is a preview of subscription content, access via your institution.

    Reference

    1. Tucker MD, et al. Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports. Frontiers in Oncology 10: 609235, 22 Dec 2020. Available from: URL: http://doi.org/10.3389/fonc.2020.609235

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Axitinib/nivolumab/pembrolizumab. Reactions Weekly 1843, 67 (2021). https://doi.org/10.1007/s40278-021-91169-1

    Download citation